榴莲视频

While cancer mortality continues to decline, the number of new cases is projected to top 2 million in 2024, according to the American Cancer Society's .

The FDA approved exagamglogene autotemcel (Casgevy) for in patients 12 years and older, maker Vertex announced. This follows last month's approval of the CRISPR/Cas9 gene-editing cell therapy for sickle cell disease.

Based on results of the THOR study, the FDA for locally advanced or metastatic urothelial carcinoma in patients with susceptible FGFR3 genetic alterations who have previously been treated with at least one line of systemic therapy, including a PD-1/L1 inhibitor.

And the agency , a personalized 3D-printed oral stent solution, to help direct radiation to the target tumor area in head and neck cancer patients while reducing harmful effects to the surrounding tissue, developer Kallisio announced.

A cohort study of more than 40,000 cancer patients found that those enrolled in high-deductible health plans and had fewer visits with noncancer physicians. (JAMA Oncology)

Cord blood-derived, CD19-targeted chimeric antigen receptor natural killer (CAR-NK) therapy yielded an in a small phase I/II study involving patients with relapsed or refractory B-cell malignancies. (Nature Medicine)

Should play a role in screening for prostate cancer? (European Urology Oncology)

The U.S. Preventive Services Task Force posted a on risk assessment, genetic counseling, and genetic testing for BRCA-related cancer.

Researchers have developed a machine learning algorithm that . (Cancer Discovery)

The U.S. government is getting ready to release a at the Marine Corps Base Camp Lejeune in North Carolina. (Reuters)

Relatives of patients with myelodysplastic neoplasia, acute myeloid leukemia, or acute lymphoblastic leukemia have an , a study in Cancer Epidemiology showed.

Comment